News and updates from IPOX®, including media mentions, interviews, research and press releases.
In a Reuters article on Ambiq Micro's U.S. IPO filing, IPOX® Research Associate Lukas Muehlbauer provided analysis on the company’s plans. He noted the chip designer's customer concentration risk but also highlighted its competitive advantage in the wearables market by targeting the "AI at the edge" niche with its ultra-low-power chips.
In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the significant rights issuance planned by Saudi Arabia's ACWA Power Co. The utility company is set to undertake the Middle East's largest such deal since 2023, aiming to raise $1.9 billion to fund its strategic expansion.
In a Reuters article covering the strong market debut of Jefferson Capital, IPOX® Research Associate Lukas Muehlbauer provided commentary on the recovering U.S. IPO market. He noted the rebound is likely to be selective, "led by high-quality and long-anticipated issuers." Muehlbauer explained that an initial trading "pop" is part of the market's "healthy process of price discovery" to establish a sustainable price. Read more in the full article on the IPOX® website.
In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the challenging European IPO market. Highlighting the recent withdrawal of several listings, Muehlbauer noted that investor appetite is particularly low for private equity exits where proceeds do not benefit the company. He stated, “Deals that are essentially existing owners cashing out are proving to be a tough sell.” Read more about his analysis of the current market sentiment on our blog.
The IPOX® 100 U.S. Index (ETF: FPX) is opening at a new all-time high, extending its year-to-date gain to +21%. This surge is driven by positive market sentiment, end-of-quarter positioning, and reassuring inflation comments from the FED. Other key indexes, including the IPOX® International (FPXI) and IPOX® 100 Europe (FPXE), also closed at multi-year highs, reflecting broad strength across the IPOX® portfolio and its position as the gold standard for IPOs.
IPOX® Research Associate Lukas Muehlbauer commented on the news of Wealthfront Corporation's confidential U.S. IPO filing in a Reuters article on June 23, 2025. He noted that the move is consistent with a recent positive trend in the market, stating, "Wealthfront's IPO plans fit in with the recent uptick of successful U.S. IPOs, particularly from sectors insulated from trade and supply chain volatility."
In a Reuters article on Slide Insurance's $2.6 billion IPO, IPOX® Vice President Kat Liu provided expert insights. Liu commented on the firm's niche strategy in high-risk coastal markets and the appeal of insurer IPOs due to predictable cash flows. She also offered perspective on potential governance concerns at the newly public company, highlighting IPOX®'s expertise in analyzing new listings and market trends in the global financial sector.
In a recent Bloomberg feature, IPOX® Founder and CEO Josef Schuster analyzed the potential IPO of Vale SA’s base metals unit. He noted a listing based on its $25 billion valuation could be the most valuable mining stock debut since Glencore Plc in 2011, stating it “would definitely rank amongst the top 10 mining IPOs.” This commentary underscores the historic scale of the potential offering in the global materials sector. Read more here.
IPOX® Research Associate Dr. Lukas Muehlbauer provided commentary for Bloomberg News on the volatile debut of Saudi Arabian low-cost carrier Flynas and the company's resilience in the face of increased regional instability.